Britain's National Health Service (NHS) on Tuesday became the world's first public health body to agree to administer a new vaccine against the potentially deadly meningitis B infection.
Experts said the vaccine could potentially prevent over 4,000 cases of meningococcal disease in children under five in Britain, Xinhua reported.
Infants aged under one are most at risk of the infection, which is fatal one in 10 cases.
"We, along with our supporters, have campaigned for over two years to see the ground-breaking vaccine free on the NHS," Steve Dayman, founder of the charity Meningitis Now said.
"I'm absolutely elated that we now have this vaccine being used to protect our babies. I've waited 33 years since losing my baby to the same strain for this day to happen."
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app